Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes

Therapeutic Advances in Musculoskeletal Disease

Volumn 4, Issue 5, 2012, Pages 315-325

  Smith, Jessica W ^a   Martins, Thomas B ^b   Gopez, Evelyn ^c   Johnson, Troy ^d   Rosenberg, Thomas D ^d   Hill, Harry R ^b  

^a University of Utah   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Rosenberg Cooley Metcalf Clinic   (United States)

Author keywords

C reactive protein; inflammation; Osteoarthritis; total knee arthroplasty

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KNEE RADIOGRAPHY; LYMPHOCYTE COUNT; MALE; OSTEOARTHRITIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SHORT FORM 12; SYNOVIAL FLUID LEVEL; SYNOVIUM; TOTAL KNEE REPLACEMENT;

EID: 84869758608     PISSN: 1759720X     EISSN: 17597218     Source Type: Journal    
DOI: 10.1177/1759720X12455959     Document Type: Article

References (33)

1. Ablij H. Meinders A. (2002) C-reactive protein: history and revival. Eur J Intern Med 13: 412.
2. Bitton R. (2009) The economic burden of osteoarthritis. Am J Managed Care 15: S230–S235.
3. Conrozier T. Chappuis-Cellier C. Richard M. Mathieu P. Richard S. Vignon E. (1998) Increased serum C-reactive protein levels by immunonephelometry in subjects with rapidly destructive hip osteoarthritis. Rev Rheum Engl Ed 65: 759–765.
4. Conrozier T. Carlier M. Mathieu P. Colson F. Debard A. Richard S. et al. (2000) Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 59: 828–831.
5. Crepaldi G. Punzi L. (2003) Aging and osteoarthritis. Aging Clin Exp Res 15: 355–358.
6. Dalton R. Hoffman W. Passmore G. Martin S. (2003) Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann Clin Lab Sci 33: 435–442.
7. Di Napoli M. Papa F. (2003) Association between blood pressure and C-reactive protein levels in acute ischemic stroke. Hypertension 42: 1117–1123.
8. Elders M. (2000) The increasing impact of arthritis on public health. J Rheumatol 27: 6–8.
9. Ewald F. (1989) The Knee Society total knee arthroplasty roentgenographic evaluation and scoring system. Clin Orthopaed Rel Res 248: 9–12.
10. Fernandes J. Martel-Pelletier J. Pelletier J. (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39: 237–246.
11. Gabay C. Kusher I. (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 1376.
12. Gandhi R. Razak F. Davey J. Mahomed N. (2010) Metabolic syndrome and the functional outcomes of hip and knee arthroplasty. J Rheumatol 37: 1917–1922.
13. Hartley R. Barton-Hanson N. Finley R. Parkinson R. (2002) Early patient outcomes after primary and revision total knee arthroplasty. A prospective study. J Bone Joint Surg Br 84: 994–999.
14. Iannnone F. de Bari C. Dell'Accio F. Covelli M. Cantatore F. Patella V. et al. (2001) Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin Exp Rheumatol 19: 139–145.
15. Jones C. Cox V. Jhangri G. Suarez-Almazor M. (2012) Delineating the impact of obesity and its relationship on recovery after total joint arthroplasties. Osteoarthr Cartilage 20: 511–518.
16. Lawrence R. Felson D. Helmick C. Arnold L. Choi H. Deyo R. et al. (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheumatol 58: 26–35.
17. Leigh J.P. Seavey W. Leistikow B. (2001) Estimating the costs of job related arthritis. J Rheumatol 28: 1647–1654.
18. Luyten F. Lories R. Verschueren P. de Vlam K. Westhovens R. (2006) Contemporary concepts of inflammation, damage and repair in rheumatic disease. Best Pract Res Clin Rheumatol 20: 829–848.
19. Martins T. Pasi B. Litwin C. Hill H. (2004) Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol 11: 325–329.
20. Martins T. Pasi B. Pickering J. Jaskowski T. Litwin C. Hill H. (2002) Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. Am J Clin Pathol 118: 346–353.
21. Myers G. Christenson R. Cushman M. Ballantyne C. Cooper G. Pfeiffer C. et al. (2009) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines; Emerging Biomarkers for Primary Prevention of Cardiovascular Disease. Clin Chem 55: 378–384.
22. National Institutes of Health (2003) NIH Consensus Statement on total knee replacement. NIH Consens State Sci Statements 20: 1–32.
23. Pearle A. Scanzello C. George S. Mandl L. DiCarlo E. Peterson M. et al. (2007) Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthr Cartilage 15: 516–523.
24. Perovic-Rackov L. Pejnovic L. (2006) Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clin Rheumatol 25: 448–452.
25. Punzi L. Oliviero F. (2005) New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment. Crit Rev Clin Lab Sci 42: 279–309.
26. Scanzello C. Goldring S. (2012) The role of synovitis in osteoarthritis pathogenesis. Bone, in press.
27. Sellam J. Berenbaum F. (2010) The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 6: 625–635.
28. Sharif M. Shepstone L. Elson C. Dieppe P. Kirwan J. (2000) Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 59: 71–74.
29. Stevens-Lapsley J. Petterson S. Mizner R. Snyder-Mackler L. (2010) Impact of body mass index on functional performance after total knee arthroplasty. J Arthroplasty 25: 1104–1109.
30. Sturmer T. Brenner H. Koenig W. Gunther K. (2004) Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 6: 200–205.
31. Takahashi M. Naito K. Abe M. Sawada T. Nagano A. (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 6 (3): R208–R212.
32. Timpson N. Nordestgaard B. Harbord R. Zacho J. Frayling T. et al. (2011) C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obesity 35: 300–308.
33. Ware J. Kosinksi M. Turner-Bowker D. Gandek B. (2002) User's Manual for the SF12v2 Health Survey with a supplement Documenting SF-12 Health Survey. Lincoln, RI: Quality Metric Incorporated.